查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1715475

預填充式注射器市場：按類型、材料類型、設計、產量、製造方法、應用和分銷管道 - 2025-2030 年全球預測

Prefilled Syringes Market by Type, Material Type, Design, Volume, Manufacturing Method, Application, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計預填充式注射器市場規模在 2024 年將達到 152.3 億美元，在 2025 年將達到 163.4 億美元，預計複合年成長率為 7.71%，到 2030 年將達到 237.8 億美元。

主要市場統計數據
基準年2024年 152.3億美元
預計2025年 163.4億美元
預測年份 2030 237.8億美元
複合年成長率（%） 7.71%

在技​​術創新和加強患者照護的強烈推動下，全球預填充式注射器市場正以前所未有的速度發展。近年來，預填充式注射器的採用率越來越高，因為它們比傳統的基於管瓶的給藥機制具有明顯的優勢。預填充式注射器不僅可以提高劑量準確性，還可以最大限度地降低與污染和用藥錯誤相關的風險。

在如此動態的市場環境中，安全和效率的雙重挑戰備受相關人員關注。這些設備越來越被視為醫療保健服務的重要組成部分，因為它們解決了傳統方法的後勤挑戰。隨著研發推動產品創新，製造商目前正專注於注射器設計、材料和製造流程的進步。對具有成本效益且技術先進的解決方案的需求正在推動該市場的競爭力。

本執行摘要概述了將重新定義預填充式注射器未來的關鍵市場動態、技術進步和發展趨勢。該分析涉及市場的各個方面，並強調了影響當前情況和未來成長前景的關鍵因素。

預填充式注射器市場的變革

近年來，預填充式注射器市場發生了變革性的變化，證明該產業已準備好迎接變革和創新。製造技術的進步，加上藥物傳輸機制的進步，顯著提高了注射器的性能。特別是，技術創新正在解決與無菌性、易用性和環境永續性相關的挑戰。先進材料的整合使得預填充式注射器與更廣泛的藥物相容，從而擴大其在各個治療領域的效用。

向無針和傳統技術的轉變表明了該行業致力於改善患者體驗和安全。製造商正在投資研究，重點是克服現有設計的局限性，這推動了從傳統玻璃向先進塑膠和混合設計的轉變。這項進步不僅反映了對更易於使用的產品的需求，也凸顯了法規的變化。世界各地的監管機構都建議加強安全通訊協定，並要求公司升級生產線並遵守嚴格的品質標準。

此外，製造和供應鏈管理的數位化整合可以實現即時監控和品管，確保最終產品符合嚴格的規格。市場應對力這些變化，這一點從為滿足新的臨床需求而推出的大量產品中可以看出。因此，預填充式注射器市場正從主要的被動姿態轉向主動策略，以預測未來的醫療保健挑戰。

預填充式注射器的關鍵細分洞察

對預填充式注射器市場的詳細細分分析揭示了一個由多種因素驅動的複雜框架。首先，基於類型的評估揭示了傳統預填充式注射器和無針替代品之間的二分法。這些變化滿足了不同的臨床需求，並根據應用提供了獨特的優勢。根據材質類型，注射器可分為玻璃注射器和塑膠注射器。對於玻璃，可以考慮硼矽酸玻璃和鈉鈣玻璃，對於塑膠，可以考慮透明聚對苯二甲酸乙二醇酯和聚丙烯。

從設計來看，分為雙室型和單室型。另一方面，單室系統通常採用整合式套環和柱塞或標準柱塞設計，以確保一致性和可靠性。基於體積的細分進一步將市場分為 1ml-5ml、1ml 以下和 5ml 以上範圍，每種範圍均針對特定的劑量要求和患者屬性進行客製化。

此外，製造方法提供了對底層技術流程的洞察，包括吹灌封技術、擠壓和射出成型。這種分類不僅突顯了製造技術的多樣性，也突顯了這些方法對產品可擴展性和成本結構的影響。另一個關鍵的細分維度是應用領域，腫瘤學、風濕病學、疫苗接種等治療領域推動市場需求。透過區分化療藥物和免疫治療方法，進一步分析腫瘤產品。風濕病學按應用細分，例如抗發炎注射和緩解疾病藥物，而疫苗接種則分為成人、兒科和旅行等類別。

最後，分銷通路細分突顯了這些產品到達最終用戶的不同途徑。醫院、診所、網路藥局和零售藥局共同構成一個支持市場成長的動態網路。每個細分維度都描繪出了市場多面性的全面圖景，突顯了有針對性的創新和策略投資的機會。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 自我用藥需求增加，用藥錯誤減少
      • 慢性病盛行率的上升推動了醫療保健領域對預填充式注射器的需求
      • 疫苗接種工作和意識提高
    • 限制因素
      • 預填充式注射器低溫運輸儲運困難點
    • 機會
      • 家庭醫療保健服務的擴展推動了對易於使用的預填充式注射器解決方案的需求。
      • 新興市場的醫療保健意識和支出不斷提高
    • 任務
      • 確保不同地區的預填充式注射器的品質和安全標準一致
  • 市場區隔分析
    • 類型：傳統預填充式注射器由於其成熟的市場地位，滲透率較高
    • 分銷管道：準確的劑量和安全特性正在推動醫院和診所對預填充式注射器的需求。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章預填充式注射器市場（依類型）

  • 常規預填充式注射器
  • 無針預填充式注射器

第7章預填充式注射器市場（依材料類型）

  • 玻璃
    • 硼硼矽酸玻璃
    • 鈉鈣玻璃
  • 塑膠
    • 透明聚對苯二甲酸乙二醇酯
    • 聚丙烯

第8章預填充式注射器市場設計

  • 雙腔
    • 可爆破密封
    • 雙重密封設計
  • 單室
    • 彩色柱塞整合
    • 標準柱塞

第9章預填充式注射器市場（依銷售量）

  • 1ml～5ml
  • 小於1毫升
  • >5ml

第 10 章預填充式注射器市場（依製造方法）

  • 吹灌封技術
  • 擠壓
  • 射出成型

第11章預填充式注射器市場（依應用）

  • 腫瘤學
    • 化療藥物
    • 免疫療法
  • 風濕病學
    • 消炎注射劑
    • 緩解疾病的藥物
  • 疫苗接種
    • 成人疫苗接種
    • 兒童疫苗接種
    • 旅行疫苗接種

第12章預填充式注射器市場（依通路）

  • 醫院和診所
  • 網路藥局
  • 零售藥局

13. 美洲預填充式注射器市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

14. 亞太地區預填充式注射器市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

15. 歐洲、中東和非洲預填充式注射器市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第16章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • AbbVie Inc.
  • AptarGroup, Inc.
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Boehringer Ingelheim Pharmaceuticals, Inc
  • Catalent, Inc. by Novo Holdings A/S
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Fresenius Kabi AG
  • Gerresheimer AG
  • GlaxoSmithKline plc
  • Janssen Pharmaceuticals, Inc. by Johnson & Johnson
  • Mylan NV by Viatris Inc.
  • Nipro Europe Group Companies
  • Novartis AG
  • Pfizer, Inc.
  • Samsung Bioepis
  • Sanofi SA
  • SCHOTT Pharma
  • Shandong Weigao Group Medical Polymer Company Limited
  • SHL Medical AG
  • Stevanato Group
  • Terumo Medical Corporation
  • Teva Pharmaceutical Industries Ltd.
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG
Product Code: MRR-030EE48515C9

The Prefilled Syringes Market was valued at USD 15.23 billion in 2024 and is projected to grow to USD 16.34 billion in 2025, with a CAGR of 7.71%, reaching USD 23.78 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 15.23 billion
Estimated Year [2025] USD 16.34 billion
Forecast Year [2030] USD 23.78 billion
CAGR (%) 7.71%

The global prefilled syringes market is evolving at an unprecedented pace, marked by innovation and a robust drive toward enhanced patient care. Over recent years, the landscape has witnessed increased adoption of prefilled systems as they offer significant advantages over traditional vial-based dosing mechanisms. Prefilled syringes not only improve dosing accuracy but also minimize risks associated with contamination and medication errors.

In this dynamic market environment, stakeholders are paying closer attention to the dual imperatives of safety and efficiency. These devices are increasingly considered a critical component in healthcare delivery, as they address the logistical challenges posed by conventional methods. As research and development continue to fuel product innovation, manufacturers are now focusing on advancing syringe designs, materials, and manufacturing processes. The need for cost-effective yet technologically advanced solutions is driving the competitive spirit in this market.

This executive summary sets the stage by outlining the key market dynamics, technological advancements, and evolving trends that are redefining the future of prefilled syringes. The analysis navigates through diverse dimensions of the market, highlighting major influences that are shaping both the current scenario and future growth prospects.

Transformative Shifts in the Prefilled Syringes Market

Recent years have seen transformative shifts in the prefilled syringes market that underscore the sector's readiness to embrace change and innovation. The evolution of manufacturing technologies, coupled with advancements in drug delivery mechanisms, has led to significant improvements in syringe performance. In particular, innovations are addressing challenges related to sterility, usability, and environmental sustainability. The integration of cutting-edge materials has enhanced the compatibility of prefilled syringes with a broader range of medications, thereby expanding their utility across various therapeutic areas.

The shift towards needle-free and conventional technologies illustrates the industry's commitment to improving patient experience and safety. Manufacturers are investing in research that focuses on overcoming limitations of existing designs, thereby catalyzing a transition from traditional glass to advanced plastic and hybrid models. This progress is not only reflective of the demand for more user-friendly products but also highlights regulatory shifts. Regulatory bodies worldwide are endorsing enhanced safety protocols, prompting companies to upgrade their production lines and adhere to strict quality standards.

Furthermore, digital integration in manufacturing and supply chain management has enabled real-time monitoring and quality control, ensuring that the end products meet exacting specifications. The market's responsiveness to these transformative shifts is evident in the robust pipeline of product launches aimed at addressing emerging clinical requirements. As a result, the prefilled syringes market is moving from a primarily reactive stance to a proactive strategy geared towards anticipating future healthcare challenges.

Key Segmentation Insights in Prefilled Syringes

A detailed segmentation analysis of the prefilled syringes market reveals a complex framework driven by multiple factors. Firstly, an evaluation based on type identifies a dichotomy between conventional prefilled syringes and needle-free alternatives. These variations cater to different clinical needs and offer unique benefits depending on the intended application. In terms of material type, the market analysis distinguishes between syringes made from glass and those manufactured from plastic. Within the glass category, borosilicate glass and soda lime glass are examined, whereas the plastic category further bifurcates into crystal-clear polyethylene terephthalate and polypropylene options.

When the design dimension is considered, the differentiation lies between dual-chamber and single-chamber configurations. In dual-chamber designs, innovations such as burstable seals and dual-seal designs facilitate improved drug stability and ease of use, while single-chamber systems often feature collar-plunger integration and standard plunger designs to ensure consistency and reliability. The segmentation based on volume further categorizes the market into ranges such as 1 ml to 5 ml, volumes less than 1 ml, and those exceeding 5 ml, each set tailored to specific dosing requirements and patient demographics.

Additionally, the manufacturing method provides insights into the underlying technological processes, spanning blow-fill-seal technology, extrusion, and injection molding. This categorization highlights not only the diversity of production techniques but also the implications of these methods on scalability and product cost structures. Another critical segmentation dimension is the application space, where therapeutic areas such as oncology, rheumatology, and vaccination drive market demand. Oncology products are further analyzed by differentiating between chemotherapy drugs and immunotherapy approaches. Rheumatology segmented applications include anti-inflammatory injections and disease-modifying drugs, while the vaccination segment is dissected into adult, pediatric, and travel vaccination categories.

Lastly, distribution channel segmentation emphasizes the varied pathways through which these products reach end-users. Hospitals and clinics, online pharmacies, as well as retail pharmacies together comprise a dynamic network that supports the market's growth. Each of these segmentation dimensions paints a comprehensive picture of the market's multifaceted nature and highlights opportunities for targeted innovation and strategic investments.

Based on Type, market is studied across Conventional Prefilled Syringes and Needle-Free Prefilled Syringes.

Based on Material Type, market is studied across Glass and Plastic. The Glass is further studied across Borosilicate Glass and Soda Lime Glass. The Plastic is further studied across Crystal-clear Polyethylene Terephthalate and Polypropylene.

Based on Design, market is studied across Dual-Chamber and Single-Chamber. The Dual-Chamber is further studied across Burstable Seals and Dual-Seal Design. The Single-Chamber is further studied across Collar-Plunger Integration and Standard Plunger.

Based on Volume, market is studied across 1 ml - 5 ml, < 1 ml, and > 5 ml.

Based on Manufacturing Method, market is studied across Blow-Fill-Seal Technology, Extrusion, and Injection Molding.

Based on Application, market is studied across Oncology, Rheumatology, and Vaccination. The Oncology is further studied across Chemotherapy Drugs and Immunotherapy. The Rheumatology is further studied across Anti-inflammatory Injections and Disease Modifying Drugs. The Vaccination is further studied across Adult Vaccination, Pediatric Vaccination, and Travel Vaccination.

Based on Distribution Channel, market is studied across Hospitals & Clinics, Online Pharmacies, and Retail Pharmacies.

Key Regional Insights Across Major Global Markets

Geographical analysis of the prefilled syringes market reveals significant regional variances, with insights drawn from major markets such as the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, well-established healthcare infrastructures paired with rising demand for advanced drug delivery systems have fostered rapid market growth. The maturation of the market in this region is driven by both technological advancements and heightened regulatory scrutiny aimed at ensuring the highest quality standards.

In Europe, Middle East & Africa, stringent regulatory policies and a keen focus on patient safety complement the rapid integration of innovative syringe designs. These regions have demonstrated an evolving preference for both conventional and needle-free prefilled syringe systems, which are seamlessly integrated into contemporary healthcare practices.

Asia-Pacific, on the other hand, presents a vibrant and expanding market marked by significant investments in healthcare technology. Rapid industrialization, increasing healthcare awareness, and improving infrastructure collectively create a conducive environment for market penetration. The diversity of healthcare needs in this region is driving customization and localized manufacturing strategies, enabling manufacturers to tailor their product offerings effectively. Overall, these regional insights underscore the importance of adapting market strategies to regional strengths and challenges.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Major Companies Shaping the Prefilled Syringes Market

Consolidation and innovation in the prefilled syringes market are being propelled by a cadre of prominent companies. This competitive outlook includes established players such as AbbVie Inc. and AptarGroup, Inc., which have built a reputation for integrating high precision and innovative drug delivery solutions. Baxter International, Inc. and Becton, Dickinson and Company continue to strengthen their market positions through robust research and development, ensuring continuous improvement in syringe design and safety features.

Global firms like Boehringer Ingelheim Pharmaceuticals, Inc, Catalent, Inc. by Novo Holdings A/S, and Eli Lilly and Company have also significantly influenced market dynamics, leveraging expansive distribution networks and advanced manufacturing capabilities. In addition, F. Hoffmann-La Roche Ltd. and Fresenius Kabi AG are recognized for their commitments to quality and innovation, while Gerresheimer AG and GlaxoSmithKline plc reinforce market leadership through comprehensive product portfolios.

Janssen Pharmaceuticals, Inc. by Johnson & Johnson and Mylan N.V. by Viatris Inc. have made notable strides in aligning technological advancements with evolving consumer needs. Other influential companies including Nipro Europe Group Companies, Novartis AG, Pfizer, Inc., and Samsung Bioepis contribute to a diversified and resilient market structure. The sustained excellence of companies such as Sanofi S.A, SCHOTT Pharma, Shandong Weigao Group Medical Polymer Company Limited, SHL Medical AG, Stevanato Group, Terumo Medical Corporation, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services, Inc., and Ypsomed AG have further catalyzed market growth and innovation, all driving the industry forward with an unwavering commitment to quality and performance.

The report delves into recent significant developments in the Prefilled Syringes Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AptarGroup, Inc., Baxter International, Inc., Becton, Dickinson and Company, Boehringer Ingelheim Pharmaceuticals, Inc, Catalent, Inc. by Novo Holdings A/S, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Fresenius Kabi AG, Gerresheimer AG, GlaxoSmithKline plc, Janssen Pharmaceuticals, Inc. by Johnson & Johnson, Mylan N.V. by Viatris Inc., Nipro Europe Group Companies, Novartis AG, Pfizer, Inc., Samsung Bioepis, Sanofi S.A, SCHOTT Pharma, Shandong Weigao Group Medical Polymer Company Limited, SHL Medical AG, Stevanato Group, Terumo Medical Corporation, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services, Inc., and Ypsomed AG. Actionable Recommendations for Market Leaders

To remain at the forefront of the prefilled syringes market, industry leaders should prioritize strategic investments in research and development to harness the latest technological advances and meet the rising demand for innovative drug delivery systems. An emphasis on sustainable and scalable manufacturing practices is essential. Investing in modern production techniques, such as blow-fill-seal and injection molding, not only streamlines operations but also ensures product integrity.

Additionally, companies should enhance collaboration with regulatory bodies to perfectly align with evolving safety standards, thus mitigating potential compliance issues. Embracing a multi-dimensional segmentation strategy that carefully considers product type, material attributes, design complexities, volume specifications, and therapeutic applications is critical for staying competitive. Leaders are encouraged to integrate comprehensive market intelligence and forecasting tools to better anticipate market shifts and consumer preferences.

Expanding distribution channels-particularly in rapidly growing regions such as Asia-Pacific-will be paramount. Strengthening digital partnerships and leveraging online platforms can effectively boost accessibility and overall market reach. By implementing these actionable recommendations, decision-makers can secure a competitive edge, drive operational efficiency, and meet the strategic challenges head-on in an increasingly dynamic marketplace.

Conclusion of the Prefilled Syringes Market Research

In conclusion, the comprehensive analysis of the prefilled syringes market highlights its rapid evolution driven by technological advancements, diversified segmentation, and strategic regional expansions. The market is being reshaped by significant transformative improvements that are addressing challenges related to usability, product safety, and cost efficiency. With the interplay of robust segmentation frameworks and an expansive range of applications across therapeutic areas, prefilled syringes are poised to play an integral part in modern healthcare delivery.

The findings underscore the compelling need for healthcare professionals and industry stakeholders to stay informed about emerging trends and continuously recalibrate their strategies to align with dynamic market demands. As innovation and regulatory evolutions continue to intersect, this report offers a roadmap for navigating future opportunities and challenges with confidence and strategic foresight.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for self-administration of drugs and reducing medication errors
      • 5.1.1.2. Increasing prevalence of chronic diseases boosts demand for prefilled syringes in healthcare
      • 5.1.1.3. Rising vaccination initiatives and awareness
    • 5.1.2. Restraints
      • 5.1.2.1. Difficulties in the cold chain storage and transportation of prefilled syringes
    • 5.1.3. Opportunities
      • 5.1.3.1. Expansion of home healthcare services fuels the need for easy-to-use prefilled syringe solutions
      • 5.1.3.2. Rising healthcare awareness and expenditure in emerging markets
    • 5.1.4. Challenges
      • 5.1.4.1. Ensuring consistent quality and safety standards for prefilled syringes across different regions
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type : Higher proliferation of conventional prefilled syringes due to their established market presence
    • 5.2.2. Distribution Channel :Growing need for prefilled syringes in hospitals & clinics due to their precise dosage and safety features
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Prefilled Syringes Market, by Type

  • 6.1. Introduction
  • 6.2. Conventional Prefilled Syringes
  • 6.3. Needle-Free Prefilled Syringes

7. Prefilled Syringes Market, by Material Type

  • 7.1. Introduction
  • 7.2. Glass
    • 7.2.1. Borosilicate Glass
    • 7.2.2. Soda Lime Glass
  • 7.3. Plastic
    • 7.3.1. Crystal-clear Polyethylene Terephthalate
    • 7.3.2. Polypropylene

8. Prefilled Syringes Market, by Design

  • 8.1. Introduction
  • 8.2. Dual-Chamber
    • 8.2.1. Burstable Seals
    • 8.2.2. Dual-Seal Design
  • 8.3. Single-Chamber
    • 8.3.1. Collar-Plunger Integration
    • 8.3.2. Standard Plunger

9. Prefilled Syringes Market, by Volume

  • 9.1. Introduction
  • 9.2. 1 ml - 5 ml
  • 9.3. < 1 ml
  • 9.4. > 5 ml

10. Prefilled Syringes Market, by Manufacturing Method

  • 10.1. Introduction
  • 10.2. Blow-Fill-Seal Technology
  • 10.3. Extrusion
  • 10.4. Injection Molding

11. Prefilled Syringes Market, by Application

  • 11.1. Introduction
  • 11.2. Oncology
    • 11.2.1. Chemotherapy Drugs
    • 11.2.2. Immunotherapy
  • 11.3. Rheumatology
    • 11.3.1. Anti-inflammatory Injections
    • 11.3.2. Disease Modifying Drugs
  • 11.4. Vaccination
    • 11.4.1. Adult Vaccination
    • 11.4.2. Pediatric Vaccination
    • 11.4.3. Travel Vaccination

12. Prefilled Syringes Market, by Distribution Channel

  • 12.1. Introduction
  • 12.2. Hospitals & Clinics
  • 12.3. Online Pharmacies
  • 12.4. Retail Pharmacies

13. Americas Prefilled Syringes Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Prefilled Syringes Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Prefilled Syringes Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Scenario Analysis
    • 16.3.1. BD expands production and innovation in prefillable syringes for biologics
    • 16.3.2. Bora Pharmaceuticals acquires Baltimore facility from Emergent BioSolutions to expand North American footprint and enhance prefilled syringe production
    • 16.3.3. SCHOTT Pharma and KORU Medical Systems collaborate to innovate large-volume subcutaneous infusion solutions
    • 16.3.4. ROVI to enhance market presence and revenue with new pre-filled syringe manufacturing agreement, focusing on convenience, safety, and sustainability
    • 16.3.5. Schott Pharma expands U.S. operations with new prefillable syringe facility boosting production capacity and market penetration
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. AptarGroup, Inc.
  • 3. Baxter International, Inc.
  • 4. Becton, Dickinson and Company
  • 5. Boehringer Ingelheim Pharmaceuticals, Inc
  • 6. Catalent, Inc. by Novo Holdings A/S
  • 7. Eli Lilly and Company
  • 8. F. Hoffmann-La Roche Ltd.
  • 9. Fresenius Kabi AG
  • 10. Gerresheimer AG
  • 11. GlaxoSmithKline plc
  • 12. Janssen Pharmaceuticals, Inc. by Johnson & Johnson
  • 13. Mylan N.V. by Viatris Inc.
  • 14. Nipro Europe Group Companies
  • 15. Novartis AG
  • 16. Pfizer, Inc.
  • 17. Samsung Bioepis
  • 18. Sanofi S.A
  • 19. SCHOTT Pharma
  • 20. Shandong Weigao Group Medical Polymer Company Limited
  • 21. SHL Medical AG
  • 22. Stevanato Group
  • 23. Terumo Medical Corporation
  • 24. Teva Pharmaceutical Industries Ltd.
  • 25. West Pharmaceutical Services, Inc.
  • 26. Ypsomed AG

LIST OF FIGURES

  • FIGURE 1. PREFILLED SYRINGES MARKET MULTI-CURRENCY
  • FIGURE 2. PREFILLED SYRINGES MARKET MULTI-LANGUAGE
  • FIGURE 3. PREFILLED SYRINGES MARKET RESEARCH PROCESS
  • FIGURE 4. PREFILLED SYRINGES MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL PREFILLED SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 21. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 25. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 29. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 30. PREFILLED SYRINGES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 31. PREFILLED SYRINGES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PREFILLED SYRINGES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PREFILLED SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PREFILLED SYRINGES MARKET DYNAMICS
  • TABLE 7. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY CONVENTIONAL PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY NEEDLE-FREE PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY GLASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY BOROSILICATE GLASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY SODA LIME GLASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY CRYSTAL-CLEAR POLYETHYLENE TEREPHTHALATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY BURSTABLE SEALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DUAL-SEAL DESIGN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY COLLAR-PLUNGER INTEGRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY STANDARD PLUNGER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY 1 ML - 5 ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY < 1 ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY > 5 ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY BLOW-FILL-SEAL TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY CHEMOTHERAPY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY ANTI-INFLAMMATORY INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DISEASE MODIFYING DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY ADULT VACCINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY PEDIATRIC VACCINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY TRAVEL VACCINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 96. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 106. CANADA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. CANADA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. CANADA PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. CANADA PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 110. CANADA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 118. MEXICO PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 119. MEXICO PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 120. MEXICO PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. MEXICO PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. MEXICO PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. MEXICO PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 124. MEXICO PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 132. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 133. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 158. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 160. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 162. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 164. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 168. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. CHINA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. CHINA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. CHINA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 172. CHINA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 173. CHINA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 174. CHINA PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 175. CHINA PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 176. CHINA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 177. CHINA PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 178. CHINA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. CHINA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. CHINA PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. CHINA PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 182. CHINA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. INDIA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. INDIA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. INDIA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 186. INDIA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 187. INDIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 188. INDIA PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 189. INDIA PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 190. INDIA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 191. INDIA PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 192. INDIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. INDIA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. INDIA PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. INDIA PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 196. INDIA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 197. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 200. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 201. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 202. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 203. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 204. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 205. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 206. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 210. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. JAPAN PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. JAPAN PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. JAPAN PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 214. JAPAN PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 215. JAPAN PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 216. JAPAN PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 217. JAPAN PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 218. JAPAN PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 219. JAPAN PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 220. JAPAN PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. JAPAN PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. JAPAN PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. JAPAN PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 224. JAPAN PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 225. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 228. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 229. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 230. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 231. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 232. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 233. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 234. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 236. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 238. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 239. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 242. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 243. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 244. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 245. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 246. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 247. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 248. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 250. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 252. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 253. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 256. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 257. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 258. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 259. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 260. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 261. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 262. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 264. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 265. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 266. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 267. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 270. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 271. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 272. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 273. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 281. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 284. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 285. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 286. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 287. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 288. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 289. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 290. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 291. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 292. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 293. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 294. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 295. THAILAND PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. THAILAND PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 297. THAILAND PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 298. THAILAND PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 299. THAILAND PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 300. THAILAND PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 301. THAILAND PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 302. THAILAND PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 303. THAILAND PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 304. THAILAND PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 305. THAILAND PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 306. THAILAND PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 307. THAILAND PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 308. THAILAND PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 309. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 312. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 313. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 314. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 315. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 316. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 317. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 318. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 319. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 320. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 321. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 322. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 323. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 324. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 325. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 326. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 327. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 328. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 329. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 330. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 331. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 332. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 333. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 334. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 335. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 336. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 337. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 338. DENMARK PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 339. DENMARK PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 340. DENMARK PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 341. DENMARK PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 342. DENMARK PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 343. DENMARK PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 344. DENMARK PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 345. DENMARK PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 346. DENMARK PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 347. DENMARK PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 348. DENMARK PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 349. DENMARK PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 350. DENMARK PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 351. DENMARK PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 352. EGYPT PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)

T